Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 21139329)

1.

Ouabain exacerbates botulinum neurotoxin-induced muscle paralysis via progression of muscle atrophy in mice.

Fujikawa R, Muroi Y, Unno T, Ishii T.

J Toxicol Sci. 2010 Dec;35(6):795-805.

2.

Differential response of pig masseter to botulinum neurotoxin serotypes a and b.

Liu ZJ, Rafferty KL, Ye W, Herring SW.

Muscle Nerve. 2015 Jul;52(1):88-93. doi: 10.1002/mus.24492. Epub 2015 May 29.

PMID:
26039454
3.

What Is the Time to Muscle Relaxation After Intramuscular Administration of Neuromuscular Blockers?

Shaw I, Trueger NS, Pirotte MJ.

Ann Emerg Med. 2015 May 8. pii: S0196-0644(15)00307-8. doi: 10.1016/j.annemergmed.2015.04.013. [Epub ahead of print] Review. No abstract available.

PMID:
25964083
4.

Heat shock protein 70 overexpression does not attenuate atrophy in botulinum neurotoxin type A-treated skeletal muscle.

Houston FE, Hain BA, Adams TJ, Houston KL, O'Keeffe R, Dodd SL.

J Appl Physiol (1985). 2015 Jul 1;119(1):83-92. doi: 10.1152/japplphysiol.00233.2015. Epub 2015 May 7.

PMID:
25953835
5.

Improved bioassays using a local effect, such as muscle paralysis, as an endpoint.

Cevc G.

Toxicon. 2015 Jun 1;99:89-94. doi: 10.1016/j.toxicon.2015.03.012. Epub 2015 Mar 21.

PMID:
25804992
6.

Botulinum Toxin-induced Muscle Paralysis Inhibits Heterotopic Bone Formation.

Ausk BJ, Gross TS, Bain SD.

Clin Orthop Relat Res. 2015 Mar 25. [Epub ahead of print]

PMID:
25804882
7.

Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections.

Minamoto VB, Suzuki KP, Bremner SN, Lieber RL, Ward SR.

Muscle Nerve. 2015 Jan 19. doi: 10.1002/mus.24576. [Epub ahead of print]

PMID:
25598004
8.

The effects of a sublethal dose of botulinum serotype e on the swimming performance of channel catfish fingerlings.

Beecham R, Thomas T, Gao DX, Gaunt PS.

J Aquat Anim Health. 2014 Sep;26(3):149-53. doi: 10.1080/08997659.2014.902873.

PMID:
25229485
9.

Embryonic stem cells improve skeletal muscle recovery after extreme atrophy in mice.

Artioli GG, De Oliveira Silvestre JG, Guilherme JP, Baptista IL, Ramos GV, Da Silva WJ, Miyabara EH, Moriscot AS.

Muscle Nerve. 2015 Mar;51(3):346-52. doi: 10.1002/mus.24320. Epub 2015 Jan 7.

PMID:
24934406
10.

Mechano- and metabosensitive alterations after injection of botulinum toxin into gastrocnemius muscle.

Caron G, Rouzi T, Grelot L, Magalon G, Marqueste T, Decherchi P.

J Neurosci Res. 2014 Jul;92(7):904-14. doi: 10.1002/jnr.23370. Epub 2014 Feb 25.

PMID:
24615939
11.

Type A botulinum neurotoxin complex proteins differentially modulate host response of neuronal cells.

Wang L, Sun Y, Yang W, Lindo P, Singh BR.

Toxicon. 2014 May;82:52-60. doi: 10.1016/j.toxicon.2014.02.004. Epub 2014 Feb 21.

12.

Systems analysis of transcriptional data provides insights into muscle's biological response to botulinum toxin.

Mukund K, Mathewson M, Minamoto V, Ward SR, Subramaniam S, Lieber RL.

Muscle Nerve. 2014 Nov;50(5):744-58. doi: 10.1002/mus.24211. Epub 2014 Mar 17.

13.

Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals.

Mukai Y, Shimatani Y, Sako W, Asanuma K, Nodera H, Sakamoto T, Izumi Y, Kohda T, Kozaki S, Kaji R.

Toxicon. 2014 Apr;81:32-6. doi: 10.1016/j.toxicon.2013.12.012. Epub 2014 Feb 1.

PMID:
24495439
14.

Molecular mechanisms of treadmill therapy on neuromuscular atrophy induced via botulinum toxin A.

Tsai SW, Chen HL, Chang YC, Chen CM.

Neural Plast. 2013;2013:593271. doi: 10.1155/2013/593271. Epub 2013 Nov 12. Review.

15.

Acute and chronic effects of botulinum neurotoxin a on the mammalian neuromuscular junction.

Baskaran P, Thyagarajan B.

Muscle Nerve. 2014 Aug;50(2):206-15. doi: 10.1002/mus.24119. Epub 2014 May 9.

PMID:
24218344
16.

Retraction: Small-molecule quinolinol inhibitor identified provides protection against BoNT/A in mice.

[No authors listed]

PLoS One. 2013 Sep 5;8(9). doi: 10.1371/annotation/049f74d0-919f-483c-a488-4740ec0a5f4d. eCollection 2013. No abstract available.

17.

Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.

Baskaran P, Lehmann TE, Topchiy E, Thirunavukkarasu N, Cai S, Singh BR, Deshpande S, Thyagarajan B.

Toxicon. 2013 Sep;72:71-80. doi: 10.1016/j.toxicon.2013.06.014. Epub 2013 Jun 25.

18.

The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.

Broide RS, Rubino J, Nicholson GS, Ardila MC, Brown MS, Aoki KR, Francis J.

Toxicon. 2013 Sep;71:18-24. doi: 10.1016/j.toxicon.2013.05.004. Epub 2013 May 23.

PMID:
23707612
19.

A pharmacodynamic comparison study of different botulinum toxin type A preparations.

Kim SB, Ban B, Jung KS, Yang GH.

Dermatol Surg. 2013 Jan;39(1 Pt 2):150-4. doi: 10.1111/dsu.12070.

PMID:
23301818
20.

Botulinum toxin type A injections in the psoas muscle of children with cerebral palsy: muscle atrophy after motor end plate-targeted injections.

Van Campenhout A, Verhaegen A, Pans S, Molenaers G.

Res Dev Disabil. 2013 Mar;34(3):1052-8. doi: 10.1016/j.ridd.2012.11.016. Epub 2013 Jan 4.

PMID:
23295965
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk